Gut microbiota composition and its metabolites in different stages of chronic kidney disease

Tso Hsiao Chen, Chao Wei Liu, Yi Hsien Ho, Chun Kai Huang, Ching Sheng Hung, Barry H. Smith, Jung Chun Lin

研究成果: 雜誌貢獻文章同行評審

9 引文 斯高帕斯(Scopus)


A growing body of study have documented the association of gut dysbiosis or fecal metabolites with chronic kidney disease (CKD). However, it is not clear whether the phenomenon simply reflects the microenvironment changes correlated with the CKD severity or contributes to the progression of CKD. In this study, we identified the gut microbiota and metabolite in feces samples correlated with CKD severity using the Nanopore long-read sequencing platform and UPLC-coupled MS/MS approach. A cross-sectional cohort study was performed from 1 June 2020 to 31 December 2020. One hundred and fifty-six clinical participants, including 60 healthy enrollees and 96 Stage 1–5 CKD patients, were enrolled in this study. The ROC curve generated with the relative abundance of Klebsiella pneumonia or S-Adenosylhomocysteine showed a gradual increase with the CKD severity. Our results further revealed the positive correlation of increased K. pneumonia and S-Adenosylhomocysteine in gut environment, which may be of etiological importance to the deterioration of a CKD patient. In that sense, the microbiota or metabolite changes constitute potential candidates for evaluating the progression of CKD.

期刊Journal of Clinical Medicine
出版狀態已發佈 - 9月 1 2021

ASJC Scopus subject areas

  • 一般醫學


深入研究「Gut microbiota composition and its metabolites in different stages of chronic kidney disease」主題。共同形成了獨特的指紋。